Literature DB >> 8905629

Quantitation of glycerophosphorylcholine by flow injection analysis using immobilized enzymes.

A Mancini1, F Del Rosso, R Roberti, P Caligiana, A Vecchini, L Binaglia.   

Abstract

A method for quantitating glycerophosphorylcholine by flow injection analysis is reported in the present paper. Glycerophosphorylcholine phosphodiesterase and choline oxidase, immobilized on controlled porosity glass beads, are packed in a small reactor inserted in a flow injection manifold. When samples containing glycerophosphorylcholine are injected, glycerophosphorylcholine is hydrolyzed into choline and sn-glycerol-3-phosphate. The free choline produced in this reaction is oxidized to betain and hydrogen peroxide. Hydrogen peroxide is detected amperometrically. Quantitation of glycerophosphorylcholine in samples containing choline and phosphorylcholine is obtained inserting ahead of the reactor a small column packed with a mixed bed ion exchange resin. The time needed for each determination does not exceed one minute. The present method, applied to quantitate glycerophosphorylcholine in samples of seminal plasma, gave results comparable with those obtained using the standard enzymatic-spectrophotometric procedure. An alternative procedure, making use of co-immobilized glycerophosphorylcholine phosphodiesterase and glycerol-3-phosphate oxidase for quantitating glycerophosphorylcholine, glycerophosphorylethanolamine and glycerophosphorylserine is also described.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8905629     DOI: 10.1007/bf00227533

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  9 in total

1.  Determination of phosphatidylcholine in a flow injection system using immobilized enzyme reactors.

Authors:  M Masoom; R Roberti; L Binaglia
Journal:  Anal Biochem       Date:  1990-06       Impact factor: 3.365

2.  Simple, rapid enzymatic determination of glycerophosphocholine in human seminal plasma.

Authors:  H J Chap; J P Moatti; R Mieusset; M Nieto; G Laneelle; P J Bennet; A Mansat; F Pontonnier; L Douste-Blazy
Journal:  Clin Chem       Date:  1988-01       Impact factor: 8.327

Review 3.  Intracellular phospholipases A.

Authors:  H van den Bosch
Journal:  Biochim Biophys Acta       Date:  1980-09-30

4.  Levels of phospholipid catabolic intermediates, glycerophosphocholine and glycerophosphoethanolamine, are elevated in brains of Alzheimer's disease but not of Down's syndrome patients.

Authors:  J K Blusztajn; I Lopez Gonzalez-Coviella; M Logue; J H Growdon; R J Wurtman
Journal:  Brain Res       Date:  1990-12-17       Impact factor: 3.252

5.  Evidence for a membrane defect in Alzheimer disease brain.

Authors:  R M Nitsch; J K Blusztajn; A G Pittas; B E Slack; J H Growdon; R J Wurtman
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-01       Impact factor: 11.205

6.  Glycerylphosphorylcholine in selected forms of male infertility.

Authors:  P Giovenco; J C Calamera; F Dondero; R Pacifici; O Vilar
Journal:  Andrologia       Date:  1986 Mar-Apr       Impact factor: 2.775

7.  Lymphocyte activation-31P magnetic resonance studies of energy metabolism and phospholipid pathways.

Authors:  O Kaplan; J S Cohen
Journal:  Immunomethods       Date:  1994-04

8.  The phosphatidylcholine pathway of diacylglycerol formation stimulated by phorbol diesters occurs via phospholipase D activation.

Authors:  M C Cabot; C J Welsh; H T Cao; H Chabbott
Journal:  FEBS Lett       Date:  1988-06-06       Impact factor: 4.124

9.  The multidrug resistance phenotype: 31P nuclear magnetic resonance characterization and 2-deoxyglucose toxicity.

Authors:  O Kaplan; J W Jaroszewski; R Clarke; C R Fairchild; P Schoenlein; S Goldenberg; M M Gottesman; J S Cohen
Journal:  Cancer Res       Date:  1991-03-15       Impact factor: 12.701

  9 in total
  1 in total

1.  Elevated Serum Lysophosphatidylcholine in Patients with Systemic Lupus Erythematosus Impairs Phagocytosis of Necrotic Cells In Vitro.

Authors:  Gerhard E Grossmayer; Hildegard Keppeler; Sebastian Boeltz; Christina Janko; Jürgen Rech; Martin Herrmann; Kirsten Lauber; Luis E Muñoz
Journal:  Front Immunol       Date:  2018-01-17       Impact factor: 7.561

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.